The institute seminar on Wednesday November 19th will be held by Erlend B. Smeland, scientific director for the Institute for Cancer Research.
Title:"Informasjon fra instituttrådet" (in Norwegian).
Time and place: 12:00, Seminar Room, F4, Institute for Cancer Research.
From major journals, first or last author from the Institute for Cancer Research
SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples
Nucleic Acids Res (in press)
In situ expression of ERG protein in the context of tumor heterogeneity identifies prostate cancer patients with inferior prognosis
Mol Oncol (in press)
Prognostic Significance of the Loss of Heterozygosity of KRAS in Early-Stage Lung Adenocarcinoma
Front Oncol, 12, 873532